Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 029 513.4 |
96 | EP file number | EAKZ | 14 72 2474.5 |
86 | WO file number | WAKZ | PCT/US2014/030859 |
97 | EP publication number | EPN | 2971105 |
87 | WO publication number | WPN | 2014145992 |
54 | Designation/title | TI | VERFAHREN ZUR IDENTIFIZIERUNG VON ERWORBENEN IMMUNSYSTEMSREZEPTORPAAREN |
51 | IPC main class | ICM (ICMV) | C12Q 1/6844 (2018.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12Q 1/6881 (2018.01) |
22 | DE application date | DAT | Mar 17, 2014 |
96 | EP application date | EAT | Mar 17, 2014 |
86 | WO application date | WAT | Mar 17, 2014 |
43 | Date of first publication | OT | Sep 18, 2014 |
| Date of publication of grant | PET | Aug 1, 2018 |
71/73 | Applicant/owner | INH | Adaptive Biotechnologies Corporation, Seattle, WA, US; Fred Hutchinson Cancer Center, Seattle, WA, US |
72 | Inventor | IN | ROBINS, Harlan, S., Seattle, WA 98102, US |
| Address for service | | Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB, 81635 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361789408 P Mar 15, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| WO PCT/US2013/045994 Jun 14, 2013
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002971105 Searchable text:
EP000002971105 Original document:
EP000002971105B1 Searchable text:
EP000002971105B1 Original document:
WO002014145992 Searchable text:
WO002014145992 |
43 | Date of first publication | EVT | Sep 18, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Mar 4, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 6, 2025 (Show all update days)(Hide all update days)- Mar 6, 2025
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 18.09.2014: deleted
- Mar 5, 2024; Sep 7, 2023; Aug 3, 2023; Mar 9, 2023; Mar 1, 2022; Mar 12, 2021; Apr 2, 2020; Aug 21, 2019; Aug 1, 2019; Jun 20, 2019; Apr 9, 2019; Feb 14, 2019; Aug 10, 2018; Aug 7, 2018; Jul 24, 2018; Jul 19, 2018; Feb 6, 2018; Aug 3, 2017
- Historical data not available for this/these date(s)
- Mar 4, 2016
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Aug 2, 2023 |
| Issue number | HN | 36 |
| Year | PJ | 2023 |
| Publication date | VT | Sep 7, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Adaptive Biotechnologies Corporation, Seattle, WA, US; Fred Hutchinson Cancer Center, Seattle, WA, US |
71/73 | Previous applicant/owner | INHF | Adaptive Biotechnologies Corp., Seattle, Wash., US, Fred Hutchinson Cancer Research Center, Seattle, Wash., US |
| Date of update of the procedure | REGT | Sep 7, 2023 |